📣 VC round data is live. Check it out!

Physitrack Valuation Multiples

Discover Physitrack's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like ImExHS, Welby, MedApp, Metacare and more.

Physitrack Overview

About Physitrack

Physitrack PLC is a digital healthcare provider, focused on physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World.


Founded

2012

HQ

United Kingdom

Employees

86

Financials (LTM)

Revenue: $16M
EBITDA: $876K

EV

$17M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Physitrack Financials

Physitrack reported last 12-month revenue of $16M and EBITDA of $876K.

In the same LTM period, Physitrack generated $16M in gross profit, $876K in EBITDA, and had net loss of ($4M).

Revenue (LTM)


Physitrack P&L

In the most recent fiscal year, Physitrack reported revenue of $19M and EBITDA of ($2M).

Physitrack is unprofitable as of last fiscal year, with EBITDA margin of (13%) and net margin of (40%).

See analyst estimates for Physitrack
LTMLast FY202320242025202620272028
Revenue$16M$19M$18M$19M$16M
Gross Profit$16M---$16M
Gross Margin100%---100%
EBITDA$876K($2M)$8M($2M)($2M)
EBITDA Margin5%(13%)47%(13%)(16%)
EBIT Margin(24%)(12%)(3%)(12%)(45%)
Net Profit($4M)($8M)$4M($8M)($8M)
Net Margin(26%)(40%)21%(40%)(49%)
Net Debt-$5M---

Financial data powered by Morningstar, Inc.

Physitrack Stock Performance

Physitrack has current market cap of $13M, and enterprise value of $17M.

Market Cap Evolution


Physitrack's stock price is $0.82.

Physitrack share price decreased by 1.3% in the last 30 days, and by 44.5% in the last year.

Physitrack has an EPS (earnings per share) of $-0.46.

See more trading valuation data for Physitrack
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$17M$13M-0.5%-1.3%-19.0%-44.5%$-0.46

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Physitrack Valuation Multiples

Physitrack trades at 1.1x EV/Revenue multiple, and 19.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Physitrack

EV / Revenue (LTM)


Physitrack Financial Valuation Multiples

As of June 3, 2026, Physitrack has market cap of $13M and EV of $17M.

Physitrack has a P/E ratio of (3.2x).

LTMLast FY202320242025202620272028
EV/Revenue1.1x0.9x1.0x0.9x1.1x
EV/EBITDA19.7x(7.2x)2.1x(7.2x)(7.0x)
EV/EBIT(4.5x)(7.4x)(28.8x)(7.4x)(2.4x)
EV/Gross Profit1.1x---1.1x
P/E(3.2x)(1.8x)3.6x(1.8x)(1.7x)
EV/FCF-(40.8x)(19.2x)(40.8x)-

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Physitrack Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Physitrack Margins & Growth Rates

Physitrack decreased revenue by 15% but EBITDA grew by 3% in the last fiscal year.

In the most recent fiscal year, Physitrack reported EBITDA margin of (13%) and net margin of (40%).

See estimated margins and future growth rates for Physitrack

Physitrack Margins

Last FY202420252026202720282029
Gross Margin--100%100%
EBITDA Margin(13%)(13%)(16%)34%
EBIT Margin(12%)(12%)(45%)4%
Net Margin(40%)(40%)(49%)5%
FCF Margin(2%)(2%)--

Physitrack Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(15%)7%(15%)1%
Gross Profit Growth---1%
EBITDA Growth3%(129%)3%(321%)
EBIT Growth208%291%208%(110%)
Net Profit Growth4%(301%)4%(109%)
FCF Growth-(53%)--

Data powered by FactSet, Inc. and Morningstar, Inc.

Physitrack Operational KPIs

Physitrack's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Physitrack's Rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Physitrack's Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Physitrack
LTMLast FY20232024202620272028
Rule of 4012%35%--
Bessemer Rule of X22%36%--
Revenue per Employee-$0.2M--
Opex per Employee-$0.2M--
Opex to Revenue-112%103%112%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Physitrack Competitors

Physitrack competitors include ImExHS, Welby, MedApp, Metacare, NRGene, Vidavo, CurveBeam AI, iXensor, Media Lab and VSee Health.

Most Physitrack public comparables operate across Digital Therapeutics, Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
ImExHS0.6x0.5x10.0x8.3x
Welby3.4x3.4x(4.5x)-
MedApp14.0x-56.5x-
Metacare2.2x-13.1x-
NRGene1.8x-(5.8x)-
Vidavo3.9x-10.3x-
CurveBeam AI2.9x3.2x(3.5x)(3.5x)
iXensor10.8x-(7.3x)-

This data is available for Pro users. Sign up to see all Physitrack competitors and their valuation data.

Start Free Trial

Physitrack VC Funding History

Before going public, Physitrack raised $4M in total equity funding, across 3 rounds.


Physitrack Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jun-15SeedCrown Ocean Capital$2M--
Mar-15Seed-$300K--
Oct-14SeedCrown Ocean Capital$2M--

Acquisitions by Physitrack

Physitrack has acquired 3 companies to date.

Last acquisition by Physitrack was on May 6th 2022. Physitrack acquired Champion Health for $13M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Physitrack

Champion Health
Wellnow
Rehabplus
Description
Champion Health is a London-based platform delivering workplace health screenings and wellbeing services across the United Kingdom. The company conducts over 100,000 employee health checks yearly through mobile clinics and digital tools, partnering with firms like HSBC and NHS trusts. Services encompass biometric assessments, mental health support, and musculoskeletal screenings, with data dashboards for employers to track program impact.
Wellnow is a Berlin-headquartered Health-as-a-Service platform delivering on-site wellness services such as massages, yoga classes, and fitness training directly to corporate workplaces across Europe. Launched to address employee burnout, it connects companies with a network of freelance health professionals through a booking app. Wellnow leads the German market in corporate wellbeing programs.
-
HQ CountryUnited KingdomGermanyUnited Kingdom
HQ City
Sheffield
Berlin
-
Deal Date6 May 202223 Feb 20222 Mar 2021
Valuation$13M$3Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Physitrack acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Physitrack

When was Physitrack founded?Physitrack was founded in 2012.
Where is Physitrack headquartered?Physitrack is headquartered in United Kingdom.
How many employees does Physitrack have?As of today, Physitrack has over 86 employees.
Is Physitrack publicly listed?Yes, Physitrack is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Physitrack?Physitrack trades under PTRK ticker.
When did Physitrack go public?Physitrack went public in 2021.
Who are competitors of Physitrack?Physitrack main competitors include ImExHS, Welby, MedApp, Metacare, NRGene, Vidavo, CurveBeam AI, iXensor, Media Lab, VSee Health.
What is the current market cap of Physitrack?Physitrack's current market cap is $13M.
What is the current revenue of Physitrack?Physitrack's last 12 months revenue is $16M.
What is the current revenue growth of Physitrack?Physitrack revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Physitrack?Current revenue multiple of Physitrack is 1.1x.
What is the current EBITDA of Physitrack?Physitrack's last 12 months EBITDA is $876K.
What is Physitrack's EBITDA margin?Physitrack's last 12 months EBITDA margin is 5%.
What is the current EV/EBITDA multiple of Physitrack?Current EBITDA multiple of Physitrack is 19.7x.
How many companies Physitrack has acquired to date?As of June 2026, Physitrack has acquired 3 companies.
What was the largest acquisition by Physitrack?$13M acquisition of Champion Health on 6th May 2022 was the largest M&A Physitrack has done to date.
What companies Physitrack acquired?Physitrack acquired Champion Health, Wellnow, and Rehabplus.
In how many companies Physitrack has invested to date?Physitrack hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Physitrack

Lists including Physitrack

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial